Cell Membrane Capsules for Encapsulation of Chemotherapeutic and Cancer Cell Targeting in Vivo
Authors:
- 11 August 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 7 (33) , 18628-18637
Abstract
Systemic administration of chemotherapeutic agents can cause indiscriminate drug distribution and severe toxicity. Until now, encapsulation and targeting of drugs have typically relied on synthetic vehicles, which cannot minimize the clearance by the renal system and may also increase the risk of chemical side effects. Cell membrane capsules (CMCs) provide a generic and far more natural approach to the challenges of drug encapsulation and delivery in vivo. Here aptamer AS1411, which can recognize and bind overexpressed nucleolin on a cancer cell membrane, was chemically conjugated onto CMCs. As a result, AS1411 modified CMCs showed enhanced ingestion in certain cancer cells in vitro and accumulation in mouse cancer xenografts in vivo. Chemotherapeutics and contrast agents with therapeutically significant concentrations can be packaged into CMCs by reversible permeating their plasma membranes. The systematic administration of cancer targeting CMCs loaded with doxorubicin hydrochloride can significantly inhibit tumor growth in mouse xenografts, with significantly reduced toxicity compared to free drug. These findings suggest that cancer targeting CMCs may have considerable benefits in drug delivery and cancer treatment.Keywords
Funding Information
- Zhejiang Province (2013TD02)
- National Natural Science Foundation of China (51120135001)
This publication has 42 references indexed in Scilit:
- Antigen-loaded nanocarriers enhance the migration of stimulated Langerhans cells to draining lymph nodes and induce effective transcutaneous immunizationNanomedicine: Nanotechnology, Biology and Medicine, 2014
- Glioma targeting and blood–brain barrier penetration by dual-targeting doxorubincin liposomesBiomaterials, 2013
- Nanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews, 2012
- Peptide‐Mediated Blood–Brain Barrier Transport of PolymersomesAngewandte Chemie International Edition, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences, 2011
- Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular TargetingScience Translational Medicine, 2011
- Inorganic Nanoparticles as Protein MimicsScience, 2010
- Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalaseJournal of Controlled Release, 2009
- Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivativesJournal of Controlled Release, 2008
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005